Johnson & Johnson (ETR: JNJ)
Germany
· Delayed Price · Currency is EUR 138.94
-0.18 (-0.13%)
Dec 20, 2024, 5:35 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 131,900 employees as of December 31, 2023. The number of employees decreased by 20,800 or -13.62% compared to the previous year.
Employees
131,900
Change (1Y)
-20,800
Growth (1Y)
-13.62%
Revenue / Employee
€595,522
Profits / Employee
€99,715
Market Cap
333.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | 132,200 | -2,900 | -2.15% |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
| Dec 28, 2014 | Pro | Pro | Pro |
Johnson & Johnson News
- 2 days ago - Johnson & Johnson: Dividend Legend At A Discount - Seeking Alpha
- 2 days ago - Transparency in Leadership: A Business Leader’s Double-Edged Sword - CEOWORLD magazine
- 3 days ago - Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy - Seeking Alpha
- 3 days ago - Health Rounds: J&J drug helps delay multiple myeloma in high-risk patients - Reuters
- 3 days ago - Johnson & Johnson submits application to the European Medicines Agency seeking approval of a new indication for IMBRUVICA® (ibrutinib) in adult patients with previously untreated mantle cell lymphoma (MCL) who are eligible for autologous stem cell transplant - GlobeNewsWire
- 4 days ago - Johnson & Johnson says injectable Rybrevant rejected by FDA - Seeking Alpha
- 5 days ago - J&J denied extension of patent on TB drug, to benefit patients - The Times of India
- 5 days ago - US FDA declines to approve injection form of J&J's lung cancer drug - Reuters